Certara (NASDAQ:CERT) Insider Leif E. Pedersen Sells 51,224 Shares

Key Points

• Insider Leif Pedersen sold 51,224 shares of Certara at an average price of $10.92, totaling over $559,000, which decreased his holdings by 40.91%.
• Certara's stock recently traded at $10.93 with a market cap of approximately $1.76 billion and a P/E ratio of 218.64.
• The company reported $0.07 earnings per share in its last quarter, missing analysts' expectations, but achieved a 12.1% increase in revenue year-over-year.

Certara, Inc. (NASDAQ:CERT - Get Free Report) insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $10.92, for a total value of $559,366.08. Following the completion of the sale, the insider owned 73,979 shares in the company, valued at approximately $807,850.68. The trade was a 40.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Certara Stock Up 2.9%

NASDAQ:CERT traded up $0.33 during trading hours on Tuesday, hitting $11.55. The company's stock had a trading volume of 1,897,679 shares, compared to its average volume of 1,359,881. The stock has a market capitalization of $1.86 billion, a P/E ratio of 231.05 and a beta of 1.43. The stock has a fifty day moving average of $10.74 and a 200-day moving average of $11.26. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.27. Certara, Inc. has a 52-week low of $8.64 and a 52-week high of $15.69.

Certara (NASDAQ:CERT - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). Certara had a net margin of 1.97% and a return on equity of 5.11%. The business had revenue of $104.57 million during the quarter, compared to analysts' expectations of $104.14 million. During the same period last year, the company earned $0.07 EPS. The business's quarterly revenue was up 12.1% compared to the same quarter last year. On average, equities analysts forecast that Certara, Inc. will post 0.28 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on CERT shares. Zacks Research upgraded Certara from a "strong sell" rating to a "hold" rating in a research report on Friday, September 5th. Morgan Stanley assumed coverage on shares of Certara in a research report on Thursday, July 3rd. They set an "equal weight" rating and a $16.00 price target for the company. UBS Group cut their price objective on Certara from $17.50 to $15.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Finally, KeyCorp cut their price objective on Certara from $18.00 to $15.00 and set an "overweight" rating for the company in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $15.14.

Institutional Investors Weigh In On Certara

Several institutional investors and hedge funds have recently bought and sold shares of CERT. Wasatch Advisors LP grew its position in Certara by 45.7% in the 2nd quarter. Wasatch Advisors LP now owns 13,532,882 shares of the company's stock worth $158,335,000 after purchasing an additional 4,244,230 shares during the last quarter. Geneva Capital Management LLC boosted its holdings in shares of Certara by 7.8% in the second quarter. Geneva Capital Management LLC now owns 6,114,895 shares of the company's stock valued at $71,544,000 after acquiring an additional 443,206 shares in the last quarter. Teacher Retirement System of Texas boosted its holdings in shares of Certara by 25.3% in the second quarter. Teacher Retirement System of Texas now owns 5,674,485 shares of the company's stock valued at $66,391,000 after acquiring an additional 1,145,554 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in Certara by 27.1% during the second quarter. Ameriprise Financial Inc. now owns 5,460,630 shares of the company's stock worth $63,889,000 after buying an additional 1,165,064 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its holdings in Certara by 47.7% during the second quarter. Mackenzie Financial Corp now owns 2,648,549 shares of the company's stock worth $30,988,000 after buying an additional 855,222 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.